A Genetic Association Study of Serum Acute-Phase C-Reactive Protein Levels in Rheumatoid Arthritis: Implications for Clinical Interpretation

English version České info

Background:
The acute-phase increase in serum C-reactive protein (CRP) is used to diagnose and monitor infectious and inflammatory diseases. Little is known about the influence of genetics on acute-phase CRP, particularly in patients with chronic inflammation.

Methods and Findings:
We studied two independent sets of patients with chronic inflammation due to rheumatoid arthritis (total 695 patients). A tagSNP approach captured common variation at the CRP locus and the relationship between genotype and serum CRP was explored by linear modelling. Erythrocyte sedimentation rate (ESR) was incorporated as an independent marker of inflammation to adjust for the varying levels of inflammatory disease activity between patients. Common genetic variants at the CRP locus were associated with acute-phase serum CRP (for the most associated haplotype: p = 0.002, p<0.0005, p<0.0005 in patient sets 1, 2, and the combined sets, respectively), translating into an approximately 3.5-fold change in expected serum CRP concentrations between carriers of two common CRP haplotypes. For example, when ESR = 50 mm/h the expected geometric mean CRP (95% confidence interval) concentration was 43.1 mg/l (32.1–50.0) for haplotype 1 and 14.2 mg/l (9.5–23.2) for haplotype 4.

Conclusions:
Our findings raise questions about the interpretation of acute-phase serum CRP. In particular, failure to take into account the potential for genetic effects may result in the inappropriate reassurance or suboptimal treatment of patients simply because they carry low-CRP–associated genetic variants. CRP is increasingly being incorporated into clinical algorithms to compare disease activity between patients and to predict future clinical events: our findings impact on the use of these algorithms. For example, where access to effective, but expensive, biological therapies in rheumatoid arthritis is rationed on the basis of a DAS28-CRP clinical activity score, then two patients with identical underlying disease severity could be given, or denied, treatment on the basis of CRP genotype alone. The accuracy and utility of these algorithms might be improved by using a genetically adjusted CRP measurement.

: Please see later in the article for the Editors' Summary

Vyšlo v časopise: A Genetic Association Study of Serum Acute-Phase C-Reactive Protein Levels in Rheumatoid Arthritis: Implications for Clinical Interpretation. PLoS Med 7(9): e32767. doi:10.1371/journal.pmed.1000341
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1000341

Souhrn

Zdroje

1. CarlsonCS

AldredSF

LeePK

TracyRP

SchwartzSM

2005 Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am J Hum Genet 77 64 77

2. MillerDT

ZeeRY

SukDJ

KozlowskiP

ChasmanDI

2005 Association of common CRP gene variants with CRP levels and cardiovascular events. Ann Hum Genet 69 623 638

3. CrawfordDC

SandersCL

QinX

SmithJD

ShephardC

2006 Genetic variation is associated with C-reactive protein levels in the Third National Health and Nutrition Examination Survey. Circulation 114 2458 2465

4. KathiresanS

LarsonMG

VasanRS

GuoCY

GonaP

2006 Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level. Circulation 113 1415 1423

5. LangeLA

CarlsonCS

HindorffLA

LangeEM

WalstonJ

2006 Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. JAMA 296 2703 2711

6. DaneshJ

WheelerJG

HirschfieldGM

EdaS

EiriksdottirG

2004 C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350 1387 1397

7. DaneshJ

PepysMB

2009 C-reactive protein and coronary disease: is there a causal link? Circulation 120 2036 2039

8. PepysMB

HirschfieldGM

2003 C-reactive protein: a critical update. J Clin Invest 111 1805 1812

9. D'AiutoF

CasasJP

ShahT

HumphriesSE

HingoraniAD

2005 C-reactive protein (+1444C>T) polymorphism influences CRP response following a moderate inflammatory stimulus. Atherosclerosis 179 413 417

10. MotoyamaS

MiuraM

HinaiY

MaruyamaK

UsamiS

2009 C-reactive protein 1059G>C genetic polymorphism influences serum C-reactive protein levels after esophagectomy in patients with thoracic esophageal cancer. J Am Coll Surg 209 477 483

11. PerryTE

MuehlschlegelJD

LiuKY

FoxAA

CollardCD

2009 C-Reactive protein gene variants are associated with postoperative C-reactive protein levels after coronary artery bypass surgery. BMC Med Genet 10 38

12. SukDJ

ChasmanDI

CannonCP

MillerDT

ZeeRY

2006 Influence of genetic variation in the C-reactive protein gene on the inflammatory response during and after acute coronary ischemia. Ann Hum Genet 70 705 716

13. BrullDJ

SerranoN

ZitoF

JonesL

MontgomeryHE

2003 Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heart disease. Arterioscler Thromb Vasc Biol 23 2063 2069

14. RopesMW

RossmeislE

BauerW

1939 The relationship between the erythrocyte sedimentation rate and the plasma proteins. J Clin Invest 18 791 798

15. ZlonisM

1993 The mystique of the erythrocyte sedimentation rate. A reappraisal of one of the oldest laboratory tests still in use. Clin Lab Med 13 787 800

16. AnderssonR

MalmvallBE

BengtssonBA

1986 Acute phase reactants in the initial phase of giant cell arteritis. Acta Med Scand 220 365 367

17. Osei-BimpongA

MeekJH

LewisSM

2007 ESR or CRP? A comparison of their clinical utility. Hematology 12 353 357

18. SteerS

LadB

GrumleyJA

KingsleyGH

FisherSA

2005 Association of R602W in a protein tyrosine phosphatase gene with a high risk of rheumatoid arthritis in a British population: evidence for an early onset/disease severity effect. Arthritis Rheum 52 358 360

19. ArnettFC

EdworthySM

BlochDA

McShaneDJ

FriesJF

1988 The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31 315 324

20. RhodesB

MeekJ

WhittakerJC

VyseTJ

2008 Quantification of the genetic component of basal C-reactive protein expression in SLE nuclear families. Ann Hum Genet 72 611 620

21. BarrettJC

FryB

MallerJ

DalyMJ

2005 Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 263 265

22. StephensM

DonnellyP

2003 A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73 1162 1169

23. PepysMB

HirschfieldGM

TennentGA

GallimoreJR

KahanMC

2006 Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 440 1217 1221

24. RidkerPM

PareG

ParkerA

ZeeRY

DanikJS

2008 Loci related to metabolic-syndrome pathways including LEPR, HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study. Am J Hum Genet 82 1185 1192

25. VerzilliC

ShahT

CasasJP

ChapmanJ

SandhuM

2008 Bayesian meta-analysis of genetic association studies with different sets of markers. Am J Hum Genet 82 859 872

26. KushnerI

SamolsD

MagreyM

2010 A unifying biologic explanation for “high-sensitivity” C-reactive protein and “low-grade” inflammation. Arthritis Care Res (Hoboken) 62 442 446

27. FransenJ

WelsingPM

de KuijzerRM

van RielPL

2004 Disease activity scores using C-reactive protein: CRP may replace ESR in the assessment of RA disease activity. Ann Rheum Dis 62 Suppl 1 151

28. ArtzAS

WickremaA

DinnerS

GodleyLA

KocherginskyM

2008 Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 14 1209 1216

29. BajwaEK

KhanUA

JanuzziJL

GongMN

ThompsonBT

2009 Plasma C-reactive protein levels are associated with improved outcome in ARDS. Chest 136 471 480

30. KimDK

OhSY

KwonHC

LeeS

KwonKA

2009 Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer. BMC Cancer 9 155

31. KoikeY

MikiC

OkugawaY

YokoeT

ToiyamaY

2008 Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer. J Surg Oncol 98 540 544

32. KompotiM

DrimisS

PapadakiA

KotsomytisK

PoulopoulouC

2008 Serum C-reactive protein at admission predicts in-hospital mortality in medical patients. Eur J Intern Med 19 261 265

33. MoonJM

ChunBJ

2009 Predicting the complicated neutropenic fever in the emergency department. Emerg Med J 26 802 806

34. PooleCD

ConwayP

ReynoldsA

CurrieCJ

2008 The association between C-reactive protein and the likelihood of progression to joint replacement in people with rheumatoid arthritis: a retrospective observational study. BMC Musculoskelet Disord 9 146

35. van der Helm-van MilA

leCS

vanDH

BreedveldFC

ToesRE

2007 A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: how to guide individual treatment decisions. Arthritis Rheum 56 433 440

36. RhodesB

WongA

NavarraSV

VillaminC

VyseTJ

2008 Genetic determinants of basal C-reactive protein expression in Filipino systemic lupus erythematosus families. Genes Immun 9 153 160

37. RhodesB

MorrisDL

SubrahmanyanL

AubinC

de LeonCF

2008 Fine-mapping the genetic basis of CRP regulation in African Americans: a Bayesian approach. Hum Genet 123 633 642